Responses to the letter by Feka et al. regarding oral hydroquinidine as an alternative to intravenous quinidine: Quinidine for ventricular arrhythmias

Trends Cardiovasc Med. 2024 Sep 14:S1050-1738(24)00088-4. doi: 10.1016/j.tcm.2024.09.001. Online ahead of print.

Authors

Redwane Rakza¹, Pierre Groussin¹, Karim Benali², Nathalie Behar¹, Philippe Mabo¹, Dominique Pavin¹, Christophe Leclercq¹, Jackson J Liang³, Raphaël P Martins⁴

Affiliations

¹ Univ Rennes, CHU Rennes, INSERM, LTSI - UMR 1099, CHU de Rennes, 2 rue Henri Le Guilloux, Rennes F-35000, France.
² Saint-Etienne University, Saint-Etienne, France.
³ Division of Cardiovascular Medicine, University of Michigan, Ann Arbor, MI, United States.
⁴ Univ Rennes, CHU Rennes, INSERM, LTSI - UMR 1099, CHU de Rennes, 2 rue Henri Le Guilloux, Rennes F-35000, France. Electronic address: raphael.martins@chu-rennes.fr.

PMID: 39278801
DOI: 10.1016/j.tcm.2024.09.001

No abstract available

Publication types

Letter